Novel solutions to Alzheimer’s treatment and prevention are attracting significant interest due to the lack of effective pharmaceutical interventions.
Recently, exposure to 40 Hz stroboscopic light therapy, for one hour a day, resulted in slowing the progression of Alzheimer’s disease in mice and has a considerable potential for treatment of humans (short article: http://news.mit.edu/2019/brain-wave-stimulation-improve-alzheimers-0314).
However, exposure to such stroboscopic light carry its own consequences being that it is difficult to implement in patient’s daily routine, irksome to use, and can cause visual discomfort which may result in lack of patient adherence.
In this talk we will go through a new simple lighting technology, based on gamma light therapy, in which the flickering light is non-perceptible and thus not hindering vision or causing discomfort, while still inducing the necessary signals in the brain.
Frist: 11. nov. 2020 kl. 18:00